Product finder

recomWell EBV

Enzyme-linked immunosorbent assays (ELISA) for the detection of IgG and IgM antibodies
against Epstein-Barr virus (EBV) in human serum or plasma
  1. /
  2. Products & Automation
  3. /
  4. Product finder
  5. /
  6. recomWell EBV EA IgG

Mikrogen recomWell EBV tests are highly sensitive enzyme immunoassays for the detection of human antibodies against antigens of the Epstein-Barr virus. A classification into the different infection stages (initial infection, past infection) is possible due to the staggered occurrence of antibodies against different EBV antigens.

 

With recomWell EBV EBNA IgG, past infections can be reliably detected due to the very high specificity of the diagnostic EBV key antigen EBNA-1.

 

Acute EBV infections can be detected in the early phase due to the optimized antigen composition of the recomWell EBV VCA IgG and recomWell EBV IgM tests.

Products

recomWell EBV EA IgG
Reagents for 96 determinations
 Article no.: 7004 Request

recomWell EBV EBNA IgG
Reagents for 96 determinations
 Article no.: 7104 Request

recomWell EBV VCA IgG
Reagents for 96 determinations
 Article no.: 7204 Request

recomWell EBV IgM
Reagents for 96 determinations
 Article no.: 7205 Request

Advantages

  • Highest sensitivity and specificity by using recombinant antigens:
    recomWell EBV EA IgG: p54, p138 (EA - Early Antigen)
    recomWell EBV EBNA IgG: EBNA-1 (EBNA - Nuclear Antigen)
    recomWell EBV VCA IgG: p54 (EA), p23, p18 (VCA - Virus Capsid Antigen)
    recomWell EBV IgM: BZLF1 (IEA - Immediate Early Antigen), p54 (EA)
  • No rheumatoid factor treatment required with recomWell IgM test
  • Excellent discrimination between negative and positive results
  • Use of single strips possible

Safe and reliable

Fully automatic processing, software-based evaluation and connection to the laboratory information system possible

Flexible and compatible

Combination of all Mikrogen ELISA possible - uniform processing and interchangeable reagents

High Standard

CE mark: The recomWell EBV tests meet the high standard of the EC Directive 98/79/EC for in vitro diagnostic medical devices.